{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:29:32Z","timestamp":1759883372202,"version":"build-2065373602"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,7]]},"DOI":"10.7759\/cureus.94043","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T16:57:38Z","timestamp":1759856258000},"source":"Crossref","is-referenced-by-count":0,"title":["Thrombolysis in Prosthetic Valve Thrombosis: A Safe and Effective Alternative?"],"prefix":"10.7759","author":[{"given":"Mohamed Samy","family":"Lebbar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatimazahra","family":"Merzouk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Ghali","family":"Benouna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1067\/mtc.2001.116470","article-title":"Repeat heart valve surgery: risk factors for operative mortality","volume":"122","author":"Jones JM","year":"2001","unstructured":"Jones JM, O'kane H, Gladstone DJ, et al.. Repeat heart valve surgery: risk factors for operative mortality. J Thorac Cardiovasc Surg. 2001, 122:913-8. 10.1067\/mtc.2001.116470","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs486","article-title":"Urgent surgery compared with fibrinolytic therapy for the treatment of left-sided prosthetic heart valve thrombosis: a systematic review and meta-analysis of observational studies","volume":"34","author":"Karthikeyan G","year":"2013","unstructured":"Karthikeyan G, Senguttuvan NB, Joseph J, Devasenapathy N, Bahl VK, Airan B. Urgent surgery compared with fibrinolytic therapy for the treatment of left-sided prosthetic heart valve thrombosis: a systematic review and meta-analysis of observational studies. Eur Heart J. 2013, 34:1557-66. 10.1093\/eurheartj\/ehs486","journal-title":"Eur Heart J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/2048872612451169","article-title":"Prosthetic heart valve obstruction: thrombolysis or surgical treatment?","volume":"1","author":"Bonou M","year":"2012","unstructured":"Bonou M, Lampropoulos K, Barbetseas J. Prosthetic heart valve obstruction: thrombolysis or surgical treatment?. Eur Heart J Acute Cardiovasc Care. 2012, 1:122-7. 10.1177\/2048872612451169","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.035143","article-title":"Surgery versus thrombolytic therapy for the management of left-sided prosthetic valve thrombosis without hemodynamic compromise: a systematic review and meta-analysis","volume":"13","author":"Chopard R","year":"2024","unstructured":"Chopard R, Vidoni C, Besutti M, et al.. Surgery versus thrombolytic therapy for the management of left-sided prosthetic valve thrombosis without hemodynamic compromise: a systematic review and meta-analysis. J Am Heart Assoc. 2024, 13:e035143. 10.1161\/JAHA.124.035143","journal-title":"J Am Heart Assoc"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.11.018","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"77","author":"Otto CM","year":"2021","unstructured":"Otto CM, Nishimura RA, Bonow RO, et al.. 2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines. J Am Coll Cardiol. 2021, 77:e25-e197. 10.1016\/j.jacc.2020.11.018","journal-title":"J Am Coll Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"43","author":"Vahanian A","year":"2022","unstructured":"Vahanian A, Beyersdorf F, Praz F, et al.. 2021 ESC\/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2022, 43:561-632. 10.1093\/eurheartj\/ehab395","journal-title":"Eur Heart J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2005.071183","article-title":"Thrombosis of prosthetic heart valves: diagnosis and therapeutic considerations","volume":"93","author":"Roudaut R","year":"2007","unstructured":"Roudaut R, Serri K, Lafitte S. Thrombosis of prosthetic heart valves: diagnosis and therapeutic considerations. Heart. 2007, 93:137-42. 10.1136\/hrt.2005.071183","journal-title":"Heart"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-018-1710-6","article-title":"How to perform and manage low-dose and slow\/ultra-slow tissue type plasminogen activator infusion regimens in patients with prosthetic valve thrombosis","volume":"46","author":"Guner A","year":"2018","unstructured":"Guner A, Kalcik M, Gursoy MO, Gunduz S, Ozkan M. How to perform and manage low-dose and slow\/ultra-slow tissue type plasminogen activator infusion regimens in patients with prosthetic valve thrombosis. J Thromb Thrombolysis. 2018, 46:399-402. 10.1007\/s11239-018-1710-6","journal-title":"J Thromb Thrombolysis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2015.04.025","article-title":"Ultraslow thrombolytic therapy: a novel strategy in the management of PROsthetic MEchanical valve Thrombosis and the prEdictors of outcomE: The Ultra-slow PROMETEE trial","volume":"170","author":"\u00d6zkan M","year":"2015","unstructured":"\u00d6zkan M, G\u00fcnd\u00fcz S, G\u00fcrsoy OM, et al.. Ultraslow thrombolytic therapy: a novel strategy in the management of PROsthetic MEchanical valve Thrombosis and the prEdictors of outcomE: The Ultra-slow PROMETEE trial. Am Heart J. 2015, 170:409-18. 10.1016\/j.ahj.2015.04.025","journal-title":"Am Heart J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2024.132507","article-title":"Ultraslow low-dose thrombolytic therapy in patients with acute mechanical prosthetic heart valve thrombosis - a prospective cohort study","volume":"416","author":"Sadeghipour P","year":"2024","unstructured":"Sadeghipour P, Salehi M, Kohansal E, et al.. Ultraslow low-dose thrombolytic therapy in patients with acute mechanical prosthetic heart valve thrombosis - a prospective cohort study. Int J Cardiol. 2024, 416:132507. 10.1016\/j.ijcard.2024.132507","journal-title":"Int J Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2023.03.412","article-title":"Management of mechanical prosthetic heart valve thrombosis: JACC review topic of the week","volume":"81","author":"Soria Jim\u00e9nez CE","year":"2023","unstructured":"Soria Jim\u00e9nez CE, Papolos AI, Kenigsberg BB, et al.. Management of mechanical prosthetic heart valve thrombosis: JACC review topic of the week. J Am Coll Cardiol. 2023, 81:2115-27. 10.1016\/j.jacc.2023.03.412","journal-title":"J Am Coll Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.8760","article-title":"Clinical outcomes of mechanical prosthetic valve thrombosis","volume":"12","author":"Sharif Khan H","year":"2020","unstructured":"Sharif Khan H, Ijaz Z, Ali M, et al.. Clinical outcomes of mechanical prosthetic valve thrombosis. Cureus. 2020, 12:e8760. 10.7759\/cureus.8760","journal-title":"Cureus"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.001145","article-title":"Thrombolytic therapy for the treatment of prosthetic heart valve thrombosis in pregnancy with low-dose, slow infusion of tissue-type plasminogen activator","volume":"128","author":"\u00d6zkan M","year":"2013","unstructured":"\u00d6zkan M, \u00c7akal B, Karakoyun S, et al.. Thrombolytic therapy for the treatment of prosthetic heart valve thrombosis in pregnancy with low-dose, slow infusion of tissue-type plasminogen activator. Circulation. 2013, 128:532-40. 10.1161\/CIRCULATIONAHA.113.001145","journal-title":"Circulation"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/415667-thrombolysis-in-prosthetic-valve-thrombosis-a-safe-and-effective-alternative","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T16:57:38Z","timestamp":1759856258000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/415667-thrombolysis-in-prosthetic-valve-thrombosis-a-safe-and-effective-alternative"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.94043","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,7]]}}}